Challenging current asthma treatment guidelines: Improved control of asthma symptoms with nebulised budesonide in patients with severe asthma receiving continuous oral steroids

Disease Management and Health Outcomes

Volumn 7, Issue 4, 2000, Pages 217-225

  Connolly, Kevin C ^a   Peake, Michael D ^b   Halpin, David M G ^c   Golightly, Lynda ^d   Turbitt, Marlyn L ^d  

^a DARLINGTON MEMORIAL HOSPITAL   (United Kingdom)

^b Pontefract General Infirmary   (United Kingdom)

^c ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^d Astra Pharmaceuticals Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; DELTACORTRIL ENTERIC; RESPULES; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; DYSPNEA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; TREATMENT OUTCOME;

EID: 0034007342     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-200007040-00005     Document Type: Article

References (10)

1. 1. Barnes PJ, Chung KF. Difficult asthma. BMJ 1989; 299: 695-8
2. 2. British Thoracic Society, Research Unit of the Royal College of Physicians. Guidelines on the management of asthma. Thorax 1997; 52 (1): 1-24
3. 3. Mygind N. Essential allergy. Oxford: Blackwell Scientific Publications, 1996; 143-244
4. 4. Chung KF. Management of difficult asthma. Br J Hosp Med 1994; 51 (3): 80-1
5. 5. Otulana BA, Varma N, Bullock A, et al. High dose nebulised steroid in the treatment of chronic steroid-dependent asthma. Resp Med 1992; 86: 105-8
6. 6. Higginbottam TW, Clark RA, Luksza AR, et al. The role of nebulised budesonide in permitting a reduction in the dose of oral steroid in persistent severe asthma. Eur J Clin Res 1994; 5: 1-10
7. 7. Llangovan P, Pedersen S, Godfrey S, et al. Treatment of severe steroid dependent pre-school asthma with nebulised budesonide suspension. Arch Dis Child 1993; 68: 356-9
8. 8. Mohan G, MacLusky KA, Godley CC, et al. A comparison of a budesonide based and a beclomethasone/prednisolone based management strategy for the treatment of severe asthma in general practice. Herts, UK: AstraZeneca (Data on file)
9. 9. O'Connor BJ, Basran GS, O'Connell F, et al. Oral steroid sparing effect of nebulised budesonide in chronic severe asthma. Am J Respir Crit Care Med 1996; 153 (4 Pt 2): A431
10. 10. Skinner RJ, Nunn AJ, Fan Chury K, et al. Randomised, double blind, placebo controlled trial of methotrexate in steroid dependent asthma. Lancet 1990; 336: 137-40